Point and interval estimations of circadian melatonin ecphasia in Smith-Magenis syndrome

Biomedicine and Pharmacotherapy

Volumn 57, Issue SUPPL. 1, 2003, Pages 31-34

  Cornélissen, Germaine ^a   Halberg, Franz ^a   Tarquini, Roberto ^b   Perfetto, Federico ^b   Salti, Roberto ^b   Laffi, Giacomo ^b   Otsuka, Kuniaki ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF FLORENCE   (Italy)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Acrophase; Circadian; Ecphasia; Melatonin; Smith Magenis syndrome (SMS)

Indexed keywords

MELATONIN;

ADOLESCENT; ARTICLE; AUTONOMIC DYSFUNCTION; BLOOD PRESSURE; CHILD; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; DARKNESS; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SLEEP; SMITH MAGENIS SYNDROME;

EID: 0142200287     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2003.08.004     Document Type: Article

References (20)

1. Bingham C., Arbogast B., Cornélissen G., Lee J.K., Halberg F. Inferential statistical methods for estimating and comparing cosinor parameters. Chronobiologia. 9:1982;397-439.
2. Claustrat B., Brun J., Garry P., Roussel B., Sassolas G. A once-repeated study of nocturnal plasma melatonin patterns and sleep recordings in six normal young men. J Pineal Res. 3:1986;301-310.
3. Cornélissen G., Halberg F., Perfetto F., Tarquini R., Maggioni C., Wetterberg L. Melatonin involvement in cancer: methodological considerations. Bartsch C., Bartsch H., Blask D.E., Cardinali D.P., Hrushesky W.J.M., Mecke W. The pineal gland and cancer: neuroimmunoendocrine mechanisms in malignancy. 2001;117-149 Springer, Heidelberg.
4. De Leersnyder H., Bresson J.L., de Blois M.C., Souberbielle J.C., Mogenet A., Delhotal-Landes B., et al. Beta(1)-adrenergic antagonists and melatonin reset the clock and restore sleep in a circadian disorder, Smith-Magenis syndrome. J Med Genet. 40:2003;74-78.
5. De Leersnyder H., de Blois M.C., Claustrat B., Romana S., Albrecht U., von Kleist-Retzow J.C., et al. Inversion of the circadian rhythm of melatonin in the Smith-Magenis syndrome. J Pediatr. 139:2001;111-116.
6. De Leersnyder H., de Blois M.C., Vekemans M., Sidi D., Villain E., Kindermans C., et al. Beta(1)-adrenergic antagonists improve sleep and behavioural disturbances in a circadian disorder, Smith-Magenis syndrome. J Med Genet. 38:2001;586-590.
7. Dijk D.J., Cajochen C. Melatonin and the circadian regulation of sleep initiation, consolidation, structure, and the sleep EEG. J Biol Rhythms. 12:1997;627-635.
8. Greenberg F., Lewis R.A., Potocki L., Glaze D., Parke J., Killian J., et al. Multi-disciplinary clinical study of Smith-Magenis syndrome (deletion 17p11.2). Am J Med Genet. 62:1996;247-254.
9. Halberg F. Chronobiology. Ann Rev Physiol. 31:1969;675-725.
10. Halberg F., Cornélissen G., Conti C., Maestroni G., Maggioni C., Perfetto F., et al. The pineal gland and chronobiologic history: mind and spirit as feedsidewards in time structures for prehabilitation. Bartsch C., Bartsch H., Blask D.E., Cardinali D.P., Hrushesky W.J.M., Mecke W. The pineal gland and cancer: neuroimmunoendocrine mechanisms in malignancy. 2001;66-116 Springer, Heidelberg.
11. Halberg F., Halberg E., Barnum C.P., Bittner J.J. Physiologic 24-hour periodicity in human beings and mice, the lighting regimen and daily routine. Withrow R.B. Photoperiodism and related phenomena in plants and animals. 1959;803-878 Publ 55 AAAS, Washington, DC.
12. Hughes R.J., Badia P. Sleep-promoting aspects of daytime melatonin administration in humans. Sleep. 20:1997;124-131.
13. Kunz D., Bes F. Melatonin as a therapy in REM sleep behavior disorder patients: an open-labeled pilot study on the possible influence of melatonin on REM-sleep regulation. Mov Disord. 14:1999;507-511.
14. Potocki L., Glaze D., Tan D.X., Park S.S., Kashork C.D., Shaffer L.G., et al. Circadian rhythm abnormalities of melatonin in Smith-Magenis syndrome. J Med Genet. 37:2000;428-433.
15. Rocella M., Parisi L. The Smith-Magenis syndrome: a new case with infant spasms. Minerva Pediatr. 51:1999;65-71.
16. Salti R., Galluzzi F., Bindi G., Perfetto F., Tarquini R., Halberg F., et al. Nocturnal melatonin patterns in children. J Clin Endocrinol Metab. 85:2000;2137-2144.
17. Sanchez de la Peña S, Gonzalez C, Cornélissen G, Halberg F. Chronomics: time structure (chronome) of blood pressure and heart rate in health and diabetes. Abstract 27, Second International Symposium: Workshop on Chronoastrobiology and Chronotherapy, Tokyo Kasei University, Tokyo, Japan. 17 November 2001; 2 p.
18. Smith A.C.M., Gropman A.L., Bailey-Wilson J.E., Goker-Alpan O., Elsea S.H., Blancato J., et al. Hypercholesterolemia in children with Smith-Magenis syndrome: del(17)(o11.2p11.2). Genet M. 4:2002;118-125.
19. Tarquini B., Cornélissen G., Tarquini R., Perfetto F., Halberg F. General and unspecific damping by malignancy of the circadian amplitude of circulating human melatonin? Neuroendocrinol Lett. 20:1999;25-28.
20. Wetterberg L., Halberg F., Halberg E., Haus E., Kawasaki T., Ueno M., et al. Circadian characteristics of urinary melatonin from clinically healthy women at different civilization disease risk. Acta Med Scand. 220:1986;71-81.